Document is current

Article History

Received: 23 December 2020

Revised: 26 April 2021

Accepted: 27 May 2021

First Online: 16 June 2021

Ethics approval and consent to participate

: Local approval from Data Protection Officer of Centre Léon Bérard was obtained in accordance with French data protection authority requirements (<i>Commission Nationale de l’Informatique et des Libertés</i> (CNIL) MR-004 project reference INDS_090720, R201-004-040) and French and European laws and directives. Patients received an information sheet and were offered the possibility to accept or refuse to participate in this non-interventional study.

: Not applicable.

: Data supporting the findings of this study are available within the article, in the supplementary files and from the corresponding authors upon reasonable request.

: The authors declare no competing interests.

: This work was partly supported by grants of the French National Research Agency (ANR) [LabEx DEvweCAN ANR-10-LABX0061], Hospitalo Universitary Research RHU4 DEPGYN [ANR-18-RHUS-0009]; Institut National du Cancer (INCa) & Direction Générale de l’offre de soins (DGOS) [NetSARC, RREPS, RESOS, LYRICAN] [INCA-DGOS-INSERM 12563]; INCA [InterSARC]; European commission [EURACAN-EC 739521]; Fondation ARC; PIA Institut Convergence François Rabelais PLAsCAN [PLASCAN, 17-CONV-0002]; La Ligue de L’Ain contre le Cancer; La Ligue contre le Cancer funded this study. It was also partially supported by an unrestricted grant from Astra Zeneca. Role of funding source: The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. S.A., C.C., J.G., D.P. and J.Y.B. had full access to all the data of the study and had final responsibility for the decision to submit for publication.

Free to read: This content has been made available to all.